Population differences in the testosterone levels of young men are associated with prostate cancer disparities in older men

American Journal of Human Biology

Volumn 22, Issue 4, 2010, Pages 449-455

  Alvarado, Louis Calistro ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASIAN; BLOOD; CAUCASIAN; COMPARATIVE STUDY; ETHNOLOGY; HUMAN; INCIDENCE; MALE; META ANALYSIS; MIDDLE AGED; NEGRO; PROSTATE TUMOR; STATISTICS; ASIAN CONTINENTAL ANCESTRY GROUP; BLACK PERSON; PROSTATIC NEOPLASMS; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; TESTOSTERONE; YOUNG ADULT;

EID: 77953595539     PISSN: 10420533     EISSN: 15206300     Source Type: Journal    
DOI: 10.1002/ajhb.21016     Document Type: Article

References (47)

1. Bolelli G, Muti P, Micheli A, Sciajno R, Franceschetti F, Krogh V, Pisani P, Berrino F. 1995. Validity for epidemiological studies of long-term cryoconservation of steroid and protein hormones in serum and plasma. Cancer Epidemiol Biomarkers Prev 4:509-513.
2. Boots LR, Potter S, Potter D, Azziz R. 1998. Measurement of total serum testosterone levels using commercially available kits: High degree of between-kit variability. Fertil Steril 69:286-292.
3. Bribiescas R.G. 1996. Testosterone levels among Ache hunter/gatherer men: A functional interpretation of population variation among adult males. Hum Nat 7:163-188.
4. Bribiescas R.G. 2001. Reproductive ecology and life history of the human male. Yearb Phys Anthropol 44:148-176.
5. Carpenter WR, Robinson WR, Godley P.A. 2008. Getting over testosterone: Postulating a fresh start for etiologic studies of prostate cancer. J Natl Cancer Inst 100:158-159.
6. Carter HB, Pearson JD, Metter EJ, et al. 1995. Longitudinal evaluation of serum androgen levels in men with and without prostate cancer. Prostate 27:25-31.
7. CDC 2008. National Program of Cancer Registries Cancer Surveillance System. January data submission compiled in The State Cancer Profiles database. Available at:http://statecancerprofiles.cancer.gov/incidencerates/index.php
8. Curado MP, Edwards B, Shin HR,et al., editors. 2007.Cancer Incidence in Five Continents, Vol.I.X. Lyon: IAR.C. IARC Scientific Publications No. 160.
9. Eaton SB, Pike MC, Short RV, et al. 1994. Women's reproductive cancers in evolutionary context. Q Rev Biol 69:353-367.
10. Ellis L, Nyborg H. 1992. Racial/ethnic variations in male testosterone levels: A probable contributor to group differences in health. Steroids 57:72-75.
11. Ellison PT, Bribiescas RG, Bentley GR, et al. 2002. Population variation in agerelated decline in male salivary testosterone. Hum Reprod 17:3251-3253.
12. Ellison PT, Lipson SF, Meredith M.D. 1989. Salivary testosterone levels in males from the Ituri Forest of Zaire. Am J Hum Biol 1:21-24.
13. Endogenous Hormones and Prostate Cancer Collaborative Group. 2008. Endogenous sex hormones and prostate cancer: A collaborative analysis of 18 prospective studies. J Natl Cancer Inst 100:170-183.
14. Gapstur SM, Gann PH, Kopp P, Colangelo L, Longcope C, Liu K. 2002. Serum androgen concentrations in young men: A longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study. Cancer Epidemiol Biomarkers Prev 11:1041-1047.
15. Gray PB, Kruger A, Huisman HW, Wissing MP, Vorster H.H. 2006. Predictors of South African male testosterone levels: The THUSA study. Am J Hum Biol18:123-132.
16. Grönberg H. 2003. Prostate cancer epidemiology. Lancet 361:859-864.
17. Henderson BE, Ross RK, Pike MC, Casagrande J.T. 1982. Endogenous hormones as a major factor in human cancer. Cancer Res. 42:3232-3239.
18. Hsing AW, Chu LW, Stanczyk FZ. 2008. Androgen and prostate cancer: Is the hypothesis dead? Cancer Epidemiol Biomarkers Prev 17:2525-2530.
19. Jakobsson J, Ekström L, Inotsume N, et al. 2006. Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism. J Clin Endocrinol Metab 91:687-693.
20. Jankowska EA, Rogucka E, Medraś M, Welon Z. 2000. Relationships between age-related changes of sex steroids, obesity and body fat distribution among healthy Polish males. Med Sci Monit 6:1159-1164.
21. Jasieńska G, Thune I. 2001. Lifestyle, hormones, and risk of breast cancer. BMJ 322:586-587.
22. Jasieńska G, Thune I, Ellison P.T. 2000. Energetic factors, ovarian steroids and the risk of breast cancer. Eur J Cancer Prev 9:231-239.
23. Jin B, Turner L, Zhou Z, Zhou EL, Handelsman D.J. 1999. Ethnicity and migration as determinants of human prostate size. J Clin Endocrinol Metab 84:3613-3619.
24. Kamangar F, Dores GM, Anderson W.F. 2006. Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137-2150.
25. Kehinde EO, Akanji AO, Memon A, et al. 2006. Prostate cancer risk: The significance of differences in age related changes in serum conjugated and unconjugated steroid hormone concentrations between Arab and Caucasian men. Int Urol Nephrol 38:33-44.
26. Kovi J, Heshmat M.Y. 1972. Incidence of cancer in negroes in Washington, D..C. and selected African cities. Am J Epidemiol 96:401-413.
27. Marks LS, Kojima M, Demarzo A, Heber D, et al. 2004. Prostate cancer in native Japanese and Japanese-American men: Effects of dietary differences on prostatic tissue. Urology 64:765-771. (Pubitemid 39446059)
28. Morgentaler A. 2008. Guilt by association: A historical perspective on Huggins, testosterone therapy, and prostate cancer. J Sex Med 5:1834-1840.
29. Odedina FT, Ogunbiyi JO, Ukoli F.A. 2006. Roots of prostate cancer in African- American men. J Natl Med Assoc 98:539-543.
30. O'Malley B.W. 1971. Mechanism of action of steroid hormones. N Engl J Med 284:370-377.
31. Parsons JK, Carter HB, Platz EA, Wright EJ, Landis P, Metter J. 2005. Serum testosterone and the risk of prostate cancer: Potential implications for testosterone therapy. Cancer Epidemiol Biomarkers Prev 14:2257-2260.
32. Pettaway C.A. 1999. Racial differences in the androgen/androgen receptor pathway in prostate cancer. J Natl Med Assoc 91:653-660.
33. Platz EA, Giovannucci E. 2004. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer. J Steroid Biochem Mol Biol 92:237-253.
34. Rohrmann S, Nelson WG, Rifai N, et al. 2007. Serum estrogen, but not testosterone, levels differ between black and white men in a nationally representative sample of Americans. J Clin Endocrinol Metab 92:2519-2525.
35. Ross RK, Bernstein L, Judd H, Hanisch R, Pike M, Henderson B. 1986. Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst 76:45-48.
36. Ross RK, Bernstein L, Lobo RA, et al. 1992. 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 339:887-889.
37. Sánchez-Chapado M, Olmedilla G, Cabeza M, Donat E, Ruiz A. 2003. Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: An autopsy study. Prostate 54:238-247.
38. Santner SJ, Albertson B, Zhang G-Y, et al. 1998. Comparative rates of androgen production and metabolism in Caucasian and Chinese subjects. J Clin Endocrinol Metab 83:2104-2109.
39. SEER 2005. Surveillance, Epidemiology, and End Results Program. NIH Publication No. 05-4772, National Cancer Institute. Bethesda, M.D.
40. SEER 2007. November data submission compiled in The State Cancer Profiles database. National Cancer Institute, Bethesda, M.D. Available at: http://statecancerprofiles.cancer.gov/incidencerates/index.php.
41. Shaneyfelt T, Husein R, Bubley G, Mantzoros C.S. 2000. Hormonal predictors of prostate cancer: A meta-analysis. J Clin Oncol 18:847-853.
42. Sofikerim M, Eskicorapci S, Oruç O, Ozen H. 2007. Hormonal predictors of prostate cancer. Urol Int 79:13-18.
43. Tsai CJ, Cohn BA, Cirillo PM, Feldman D, Stanczyk FZ, Whittemore A.S. 2006. Sex steroid hormones in young manhood and the risk of subsequent prostate cancer: A longitudinal study in African-Americans and Caucasians (United States). Cancer Causes Control 17:1237-1244.
44. Uchida A, Bribiescas RG, Ellison PT, et al. 2006. Age related variation of salivary testosterone values in healthy Japanese males. Aging Male 9:207-213.
45. Wang C, Catlin DH, Starcevic B, et al. 2004. Testosterone metabolic clearance and production rates determined by stable isotope dilution/tandem mass spectrometry in normal men: Influence of ethnicity and age. J Clin Endocrinol Metab 89:2936-2941.
46. Winters SJ, Brufsky A, Weissfeld J, Trump DL, Dyky MA, Hadeed V. 2001. Testosterone, sex hormone-binding globulin, and body composition in young adult African American and Caucasian men. Metabolism 50: 1242-1247.
47. Wright NM, Renault J,Willi S, et al. 1995. Greater secretion of growth hormone in black than in white men: Possible factor in greater bone mineral density-A clinical research center study. J Clin Endocrinol Metab 80: 2291-2297.